ArticleCancer medicine2022

Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.

Shuyang Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.